← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M 10b5-1 Plan

$ Value

$0

Shares

2,557

Price

$0

Filed

Sep 3

Insider

Name

Megna Michael R

Title

CHIEF ACCOUNTING OFFICER

CIK

0001464583

Roles

Officer

Transaction Details

Transaction Date

2025-09-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,115

Footnotes

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. | This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $34.80 and $35.005. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. | The option is fully vested and Exercisable.

Filing Info

Accession No.

0001415889-25-023564

Form Type

4

Issuer CIK

0001730430

Megna Michael R's History

Date Ticker Type Value
2026-04-09 KNSA $309K
2026-04-07 KNSA M $4K
2026-04-07 KNSA F $82K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $154K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07